Jessica Kim Cohen

ACMG, NSGC, and others in the genetics community are monitoring whether the widely used online clinical genetics database could be at risk.

The organizations launched the clinical trial to assess clinical utility of whole-genome sequencing in cardiovascular disease care.

With drugs on the horizon for treating and possibly preventing transthyretin amyloid cardiomyopathy, cardiologists are weighing the pros and cons of genetic screening.

Researchers from the Broad Institute, Mass General, Stanford, and elsewhere are investigating why patients with South Asian ancestry are at increased risk.

The variant, present in the NFKB1 gene and common in the Aymara community, could help guide treatment decisions, researchers reported at ASH.

The Missouri hospital system designed its own 13-gene PGx panel, which it runs at its molecular genetics lab and calls the Kiddose PGx test.

Broad Institute and Northwestern University researchers are encouraging others to examine noncoding genes, when investigating undiagnosed rare diseases.

In a report, a working group cautioned that the program must lessen its reliance on congressional appropriations or risk "squandering" investments made so far.

The Australia-based startup wants to partner with drugmakers on biomarker-defined clinical trials and create clinical decision-support software.

Scores focused on the biochemical pathways associated with disease and pairing these scores with other risk assessments could improve predictive value, the data showed.